A heatmap based on the KEGG and GSEA results also revealed that genes (such as Cd36, Scd1, Scd2, Apoc3, Acot1, and Elovl3) related to lipid metabolism pathways were significantly down-regulated by leflunomide treatment compared with the WD group. The gene discussed is SCD5; the disease is Wilson disease.